ATE267191T1 - Tricyclische aminderivate - Google Patents

Tricyclische aminderivate

Info

Publication number
ATE267191T1
ATE267191T1 AT97909605T AT97909605T ATE267191T1 AT E267191 T1 ATE267191 T1 AT E267191T1 AT 97909605 T AT97909605 T AT 97909605T AT 97909605 T AT97909605 T AT 97909605T AT E267191 T1 ATE267191 T1 AT E267191T1
Authority
AT
Austria
Prior art keywords
hydrate
chem
tricyclic amine
salt
compound
Prior art date
Application number
AT97909605T
Other languages
English (en)
Inventor
Makoto Takemura
Kita-Kasai
Hisashi Takahashi
Kenichi Kimura
Rie Miyauchi
Hitoshi Ohki
Katsuhiro Kawakami
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Application granted granted Critical
Publication of ATE267191T1 publication Critical patent/ATE267191T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT97909605T 1996-10-25 1997-10-23 Tricyclische aminderivate ATE267191T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP28344696 1996-10-25
JP9125497 1997-04-10
PCT/JP1997/003842 WO1998018783A1 (en) 1996-10-25 1997-10-23 Tricyclic amine derivatives

Publications (1)

Publication Number Publication Date
ATE267191T1 true ATE267191T1 (de) 2004-06-15

Family

ID=26432708

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97909605T ATE267191T1 (de) 1996-10-25 1997-10-23 Tricyclische aminderivate

Country Status (12)

Country Link
US (2) US6384050B1 (de)
EP (1) EP0947513B1 (de)
KR (1) KR100531967B1 (de)
CN (1) CN1103769C (de)
AT (1) ATE267191T1 (de)
AU (1) AU4723197A (de)
DE (1) DE69729213T2 (de)
DK (1) DK0947513T3 (de)
ES (1) ES2221040T3 (de)
PT (1) PT947513E (de)
TW (1) TW491849B (de)
WO (1) WO1998018783A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE423776T1 (de) 1997-09-15 2009-03-15 Procter & Gamble Antimikrobielle chinolone, ihre zusammensetzungen und ihre verwendungen
AU3192700A (en) 1999-03-17 2000-10-04 Daiichi Pharmaceutical Co., Ltd. Medicinal compositions
US20040077605A1 (en) * 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
EP1854798A3 (de) * 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Kondensierte heterozyklische Succinimid-Verbindungen und Analoga daraus, Modulatoren der nuklearen Hormonrezeptorfunktion
AU3089302A (en) 2000-12-14 2002-06-24 Procter & Gamble Antimicrobial 2-pyridones, their compositions and uses
PL363323A1 (en) 2000-12-14 2004-11-15 The Procter & Gamble Company Antimicrobial quinolones
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
HUP0500096A3 (en) * 2001-12-19 2012-08-28 Bristol Myers Squibb Co Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function, process for producing them and pharmaceutical compositions containing them
TWI263640B (en) * 2001-12-19 2006-10-11 Bristol Myers Squibb Co Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
BRPI0709220A2 (pt) 2006-03-28 2011-07-12 Procter & Gamble processo de acoplamento para preparo de intermediários de quinolona
PT2001862E (pt) 2006-03-28 2011-07-20 Warner Chilcott Co Llc Sais de malato e polimorfos do ácido (3s,5s)-7-[3- amino-5-metil-piperidinil]-1-ciclopropil-1,4-dihidro- 8-metoxi-4-oxo-3-quinolinocarboxílico
EP1849770A1 (de) * 2006-04-28 2007-10-31 Laboratorios Del Dr. Esteve, S.A. Prozess für die Herstellung von bizyklischen Tetrahydropyrrolverbindungen
CN102140098A (zh) * 2010-01-29 2011-08-03 南京医科大学 7-(2-取代-3-氨基-1-四氢吡咯[3,4-c]吡唑基)喹啉羧酸衍生物及其制备方法和在抗菌抗结核上的应用
TW202517628A (zh) * 2017-09-11 2025-05-01 美商克魯松藥物公司 Shp2之八氫環戊烷并[c]吡咯別構抑制劑

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4637886A (en) 1982-12-27 1987-01-20 Exxon Research & Engineering Co. Macrocyclic polyamine and polycyclic polyamine multifunctional lubricating oil additives
JPH0676400B2 (ja) 1987-08-25 1994-09-28 大日本製薬株式会社 新規ピリドンカルボン酸誘導体、そのエステルおよびその塩
PL166381B1 (pl) * 1989-08-16 1995-05-31 Pfizer Sposób wytwarzania nowych podstawionych kwasów 7-azabicyklochinolonokarboksylowych PL PL PL PL
JP3268098B2 (ja) * 1992-12-25 2002-03-25 第一製薬株式会社 二環性環状アミン誘導体
DE4301246A1 (de) * 1993-01-19 1994-07-21 Bayer Ag Chinolon- und Naphthyridoncarbonsäurederivate
JPH0848629A (ja) * 1994-08-08 1996-02-20 Dainippon Pharmaceut Co Ltd ピリドンカルボン酸誘導体およびそれを有効成分とする抗ピロリ菌剤

Also Published As

Publication number Publication date
US6586604B2 (en) 2003-07-01
CN1103769C (zh) 2003-03-26
EP0947513A4 (de) 2002-10-02
DE69729213D1 (de) 2004-06-24
US6384050B1 (en) 2002-05-07
WO1998018783A1 (en) 1998-05-07
DK0947513T3 (da) 2004-08-30
DE69729213T2 (de) 2005-05-04
TW491849B (en) 2002-06-21
KR100531967B1 (ko) 2005-11-30
EP0947513A1 (de) 1999-10-06
ES2221040T3 (es) 2004-12-16
PT947513E (pt) 2004-09-30
CN1242011A (zh) 2000-01-19
EP0947513B1 (de) 2004-05-19
US20010037030A1 (en) 2001-11-01
KR20000052784A (ko) 2000-08-25
AU4723197A (en) 1998-05-22

Similar Documents

Publication Publication Date Title
NO950297D0 (no) Prolinamidderivater
DE69331414D1 (de) Depsipeptide, herstellung und anwendung
PT1319651E (pt) Composto 2-aminopropano-1,3-diol, sua utilizacao farmaceutica e seus intermediarios sinteticos
DE69729213D1 (de) Tricyclische aminderivate
PT718293E (pt) Composto ciclodepsipeptidico
DE3869907D1 (de) Chinolincarbonsaeure-derivate.
MX9206093A (es) Derivado de oxazolidona
CA2510468A1 (en) Novel 2,4-diamino-1,3,5-triazine derivative
ATE126796T1 (de) Quinazolinderivate und ihre herstellung.
DE68919378D1 (de) Thienotriazolodiazepine und ihre pharmazeutische Verwendung.
BR9916466A (pt) Compostos de organofósforo e seu uso
MX9206930A (es) Nuevos compuestos
DK1174131T3 (da) Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom
EP0601197A4 (de) Derivate der 5-aminochinoloncarbonsäure und sie als aktivbestandteil enthaltende antibakterielle mittel.
DE69400352D1 (de) 3- oder 4-Glykosyloxybenzopyranderivat und dieses enthaltende antiallergisches Mittel
EP0653207A4 (de) Aids-virus-infektion hemmende zusammensetzung.
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
PT816355E (pt) Derivados espiro-heterociclicos
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
TH50173A (th) การใช้ 1-ไฮดรอกซี-2-ไพริโดนสำหรับการบำบัดการติดเชื้อที่ผิวหนัง

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0947513

Country of ref document: EP

REN Ceased due to non-payment of the annual fee